Vulvar cancer epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 30: | Line 30: | ||
{| style="cellpadding=0; cellspacing= 0; width: 600px;" | {| style="cellpadding=0; cellspacing= 0; width: 600px;" | ||
|- | |- | ||
|style="padding: 0 5px; font-size: 100%; background: # | |style="padding: 0 5px; font-size: 100%; background: #4479BA; color: #FFFFFF; width: 10%" align=center |'''Race''' || style="padding: 0 5px; font-size: 100%; background: #4479BA; color: #FFFFFF; width: 10%" align=center |'''All Races''' ||style="padding: 0 5px; font-size: 100%; background: #4479BA; color: #FFFFFF; width: 10%" align=center |'''White''' || style="padding: 0 5px; font-size: 100%; background: #4479BA; color: #FFFFFF; width: 10%" align=center |'''Black''' || style="padding: 0 5px; font-size: 100%; background: #4479BA; color: #FFFFFF; width: 10%" align=center | '''Asian/Pacific Islander''' ||style="padding: 0 5px; font-size: 100%; background: #4479BA; color: #FFFFFF; width: 10%" align=center |'''American Indian/Alaska Native'''||style="padding: 0 5px; font-size: 100%; background: #4479BA; color: #FFFFFF; width: 10%" align=center |'''Hispanic'''||style="padding: 0 5px; font-size: 100%; background: #4479BA; color: #FFFFFF; width: 10%" align=center |'''Non-Hispanic''' | ||
|- | |- | ||
| style="padding: 0 5px; font-size: 100%; background: # | | style="padding: 0 5px; font-size: 100%; background: #4479BA; color: #FFFFFF; width: 10%" align=center |'''Incidence'''|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |2.4 per 100,000 ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |2.6 per 100,000 ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |1.8 per 100,000 ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |0.9 per 100,000 ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |2.0 per 100,000 || style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |1.7 per 100,000 ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |2.5 per 100,000 | ||
|} | |} | ||
==References== | ==References== | ||
Revision as of 21:09, 6 October 2015
|
Vulvar cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Vulvar cancer epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Vulvar cancer epidemiology and demographics |
|
Risk calculators and risk factors for Vulvar cancer epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Monalisa Dmello, M.B,B.S., M.D. [2]
Overview
In 2012, the incidence of vulvar cancer was estimated to be 2.4 per 100,000 females in the United States. The incidence of vulvar cancer increases with age, the median age at diagnosis is 68 years and it is more prevalent in the caucasian.[1]
Epidemiology and Demographics
Incidence
The overall age adjusted incidence rate of vulvar cancer among females is approximately 2.4 per 100,000 individuals in the United States.[1]
Age
| Age | <20 | 20-34 | 35-44 | 45-54 | 55-64 | 65-74 | 75-84 | >85 |
| Incidence | 0.2% | 2% | 6.1% | 15.3% | 19.8% | 19.8% | 22.1% | 14.9% |
Race
- Vulvar cancer is more prevalent in the caucasian.[1]
| Race | All Races | White | Black | Asian/Pacific Islander | American Indian/Alaska Native | Hispanic | Non-Hispanic |
| Incidence | 2.4 per 100,000 | 2.6 per 100,000 | 1.8 per 100,000 | 0.9 per 100,000 | 2.0 per 100,000 | 1.7 per 100,000 | 2.5 per 100,000 |
References
- ↑ 1.0 1.1 1.2 1.3 SEER Stat Fact Sheets: Vulvar Cancer. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/statfacts/html/vulva.html Accessed on September 21, 2015